Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago Wellness Today.
Press releases published on October 1, 2025
Visory Health genera ahorros de 790 millones de dólares en medicamentos cardiovasculares esenciales
ESTERO, Florida, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Visory Health, una plataforma tecnológica de salud centrada en el paciente que ofrece medicamentos con receta y que está transformando la forma en que los veteranos, las familias y los cuidadores acceden a …
New Imprivata Report Finds that Australian Hospitals Save More Than $1.2 Million AUD Annually with Shared-Use Mobile Devices, but Strategic Gaps Still Pose Security and Operational Risk
MELBOURNE, Australia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today released new research which finds that each Australian healthcare facility that …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
TOMI Environmental Solutions Appoints Harold W. Paul to Its Board of Directors
FREDERICK, Md., Oct. 01, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its …
NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer
Treatment was well-tolerated and injection feasibility was confirmed in 13 patients with locally advanced adenocarcinoma of the esophagus 85% (11/13) disease control rate (DCR) 69% (9/13) objective response rate (ORR); 6 complete responses and 3 partial …
NANOBIOTIX annonce les premières données de Phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage
Le traitement a été bien toléré et la faisabilité de l’injection a été confirmée chez les 13 patients atteints d’adénocarcinome de l’œsophage localement avancé. Le taux de contrôle de la maladie (DCR, disease control rate) était de 85 % (11/13). Le taux de …
POP Biotechnologies Awarded $2.46M NIH Grant for Alzheimer's Immunotherapy
Buffalo, NY , Oct. 01, 2025 (GLOBE NEWSWIRE) -- POP Biotechnologies, Inc. (POP BIO), has been awarded a $2.46M USD grant by the National Institutes of Health (NIH) to pursue development of a “mosaic” active immunotherapy against Alzheimer’s disease (AD). …
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
WALTHAM, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …
Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2025 financial results will be released before …
George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors
MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that George Paletta, Jr …
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CHARLESTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 116,150 restricted …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted seven newly-hired employees options to purchase an …
Artelo Biosciences Announces Closing of $2.0 Million Public Offering
SOLANA BEACH, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, …
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …
AVIDLOVE and Know Your Lemons Foundation Launch Global Three-Month “Pink Care Initiative” for Breast Health Awareness
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Lingerie brand AVIDLOVE has officially launched a global three-month campaign in partnership with the internationally recognized breast health charity Know Your Lemons Foundation. Titled “Pink is Our Promise, …
The Facial Pain Association (FPA) Highlights Trigeminal Neuralgia and the Facial Pain Community during Facial Pain Awareness Month
SUWANEE, Ga., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Throughout October, the Facial Pain Association (FPA) commemorates Facial Pain Awareness Month by honoring those living with neuropathic facial pain. The FPA, the leading national nonprofit serving this …
Cirtec Medical Appoints Steven Chevillotte to its Board of Directors
BROOKLYN PARK, Minn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a global leader in design, development, and manufacturing of complex Class II and III medical devices, is pleased to announce that Steven Chevillotte has been appointed to its Board of …
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its CORIOGRAPH Pre-Op Planning and Modeling …
Research at NTHU Finds that Kindness Can Be Taught
HSINCHU, Taiwan, Oct. 01, 2025 (GLOBE NEWSWIRE) -- When the aggressive behavior of mice is suppressed, they begin to exhibit prosocial behaviors such as allogrooming. A cross-species study conducted at National Tsing Hua University (NTHU) in Taiwan has …
Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight
New York, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight According to DelveInsight’s analysis, the market for Lyme disease is anticipated to increase during …